Ortho Clinical Diagnostics Holdings plc (OCDX): Price and Financial Metrics
OCDX Price/Volume Stats
| Current price | $17.63 | 52-week high | $22.99 |
| Prev. close | $17.55 | 52-week low | $16.04 |
| Day low | $17.47 | Volume | 5,847,500 |
| Day high | $17.79 | Avg. volume | 1,240,588 |
| 50-day MA | $18.11 | Dividend yield | N/A |
| 200-day MA | $18.78 | Market Cap | 3.92B |
OCDX Stock Price Chart Interactive Chart >
Ortho Clinical Diagnostics Holdings plc (OCDX) Company Bio
Ortho Clinical Diagnostics Holdings plc operates as a holding company. The Company, through its subsidiaries, provides vitro diagnostics products and services to the global clinical laboratory and immunohematology communities. Ortho Clinical Diagnostics Holdings serves customers worldwide.
Latest OCDX News From Around the Web
Below are the latest news stories about Ortho Clinical Diagnostics Holdings plc that investors may wish to consider to help them evaluate OCDX as an investment opportunity.
Will Ortho Clinical (OCDX) Gain on Rising Earnings Estimates?Ortho Clinical (OCDX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions. |
OCDX vs. DOCS: Which Stock Is the Better Value Option?OCDX vs. DOCS: Which Stock Is the Better Value Option? |
Wall Street Analysts See a 54% Upside in Ortho Clinical (OCDX): Can the Stock Really Move This High?The consensus price target hints at a 54.3% upside potential for Ortho Clinical (OCDX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. |
Best Value Stocks to Buy for February 18thCIVI, DBI, and OCDX made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 18, 2022 |
H.C. Wainwright Reiterates a Hold Rating on Ortho Clinical Diagnostics Holdings (OCDX)In a report released today, Yi Chen from H.C. Wainwright reiterated a Hold rating on Ortho Clinical Diagnostics Holdings (OCDX – Research Report), with a price target of $24.68. The company's shares closed last Wednesday at $16.32, close to its 52-week low of $15.53. According to TipRanks.com, Chen is a 4-star analyst with an average return of 14.7% and a 37.7% success rate. Chen covers the Healthcare sector, focusing on stocks such as HTG Molecular Diagnostics, EyePoint Pharmaceuticals, and Stealth Biotherapeutics. Currently, the analyst consensus on Ortho Clinical Diagnostics Holdings is a Moderate Buy with an average price target of $23.56. |
OCDX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -12.59% |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...